Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IKANG HEALTHCARE GROUP INC (ADR)

SummaryChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

iKang Healthcare : Termination of registration under Section 12(g) or suspension of duty to file reports

01/31/2019 | 11:44am EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES

EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-36403

IKANG HEALTHCARE GROUP, INC.

(Exact name of registrant as specified in its charter)

B-6F, Shimao Tower

92A Jianguo Road Chaoyang District, Beijing 100022

People's Republic of China

Tel: +86 10 5320 6688

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Class A Common Shares, par value US$0.01 per share

American Depositary Shares, each representing 1/2 Class A Common Shares

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)

x

Rule 12g-4(a)(2)

Rule 12h-3(b)(1)(i)

o x

Rule 12h-3(b)(1)(ii)

o

Rule 15d-6

o

Rule 15d-22(b)

o

Approximate number of holders of record as of the certification or notice date: one

Pursuant to the requirements of the Securities Exchange Act of 1934, iKang Healthcare Group, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:

January 31, 2019

iKang Healthcare Group, Inc.

By:

/s/ Lee Ligang Zhang

Name:

Lee Ligang Zhang

Title:

Chief Executive Officer

Disclaimer

iKang Healthcare Group Inc. published this content on 31 January 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 31 January 2019 16:43:02 UTC


ę Publicnow 2019
All news about IKANG HEALTHCARE GROUP INC (ADR)
2019IKANG HEALTHCARE : Termination of registration under Section 12(g) or suspension of duty t..
PU
2019IKANG HEALTHCARE : An amendment to a SC 13D filing
PU
2019iKang Announces Completion of Going Private Transaction
GL
2018iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended Septemb..
GL
2018IKANG HEALTHCARE : Amendment to a previously filed SC 13E3
PU
2018iKang Enters into Amendment No. 3 to Merger Agreement for Going Private Transaction
GL
2018iKang Schedules 2018 Unaudited Second Quarter Earnings Release on December 20, 2018
GL
2018IKANG HEALTHCARE : Amendment to a previously filed 8-A12B
PU
2018iKang Announces Unaudited Financial Results for the Fiscal First Quarter Ended June 30,..
GL
2018iKang Enters into Amendment No. 2 to Merger Agreement for Going Private Transaction
GL
More news
Chart IKANG HEALTHCARE GROUP INC (ADR)
Duration : Period :
iKang Healthcare Group Inc (ADR) Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Li Gang Zhang Chairman & Chief Executive Officer
Yang Chen Chief Financial Officer
Fei Yan Huang Chief Operating Officer & Director
Da Qing Qi Independent Non-Executive Directors
Ho Kei Man Independent Director